Resultados de la búsqueda 331-340 of 12151 for Autoimmune haemolytic anaemia

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  4. Encefalitis autoinmunitaria - Médicos y departamentos - Mayo Clinic

    Ellos llevaron a cabo el primer ensayo clínico aleatorizado de inmunoglobulina intravenosa para tratar la encefalitis autoinmune. Los investigadores también ...

  5. Transplant Center de Mayo Clinic - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation ...

  6. Pancreatitis autoinmunitaria - Síntomas y causas - Mayo Clinic

    Risk factors and treatment of relapses in autoimmune pancreatitis: Rituximab is safe and effective. United European Gastroenterology Journal. 2019; doi ...

  7. Ensayos clínicos - Hematología

    A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS). Jacksonville, Fla. The purpose of phase 2a is to ...

  8. Encefalitis autoinmunitaria - Síntomas y causas - Mayo Clinic

    Autoimmune encephalitis with antibodies to cell surface antigens. In: Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Elsevier; 2022. https ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...